VTRS - Viatris Inc
IEX Last Trade
12.49
0.030 0.240%
Share volume: 109,262
Last Updated: Thu 26 Dec 2024 08:30:21 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
1.30%
PREVIOUS CLOSE
CHG
CHG%
$12.46
0.03
0.24%
Fundamental analysis
23%
Profitability
6%
Dept financing
43%
Liquidity
55%
Performance
27%
Performance
5 Days
-0.72%
1 Month
-5.20%
3 Months
6.71%
6 Months
18.89%
1 Year
15.78%
2 Year
12.32%
Key data
Stock price
$12.49
DAY RANGE
$12.35 - $12.54
52 WEEK RANGE
$10.18 - $13.62
52 WEEK CHANGE
$14.29
DIVIDEND
$0.12
EX-DIVIDEND DATE
08/23/2024
NEXT EARNINGS DATE
11/05/2024
Company detail
CEO: Michael Goettler
Region: US
Website: viatris.com
Employees: 37,000
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: viatris.com
Employees: 37,000
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Viatris Inc. operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology. It distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies.
Recent news